Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
The first clinical success of immunotherapeutics for cancer treatment and the appreciation that tissue regeneration can be greatly improved by precisely and locally modulating the immune response are evidence that immunotherapy is poised to revolutionize the way we treat disease.
European accelerator-based X-ray facilities came together in 2017 in a consortium that will use their combined expertise to accelerate discoveries, secure funding and guide policy. A year and a half later, the chair of the consortium Helmut Dosch reflects on the ambition and opportunities of this type of cooperation.
Materials research is poised to play a pivotal role in addressing the grand challenges faced by society, from engineering better medicines to providing accessible clean water and renewable energy. However, complex problems require diverse teams. Therefore, there is an urgent need to address the diversity gap in materials science and engineering, especially for women.
Georg Bednorz, together with Karl Alexander Müller, discovered high-temperature superconductivity (HTS) in ceramics, for which they were awarded the Nobel Prize in Physics in 1987. Christine Horejs talks to Georg Bednorz about the successes and challenges of his research on HTS, applications of HTS materials, and the key ingredients for scientific discoveries.
Intelligent design of materials for biomedical applications involves the development of technologies that are informed by an understanding of biological systems. Immunoengineers have been making essential inroads in developing therapeutics endowed with designed biofunctionality, particularly in vaccinology, cancer immunotherapy and immune tolerance.
